Filing Details
- Accession Number:
- 0000899243-23-010823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-05 21:07:45
- Reporting Period:
- 2023-04-03
- Accepted Time:
- 2023-04-05 21:07:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-03 | 995 | $38.82 | 7,894 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 995 | $200.11 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-03 | 5,680 | $66.60 | 12,579 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 5,680 | $200.71 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-03 | 3,575 | $66.60 | 10,474 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 3,575 | $201.59 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-03 | 5 | $66.60 | 6,904 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 5 | $202.49 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-03 | 7,158 | $56.77 | 14,057 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 7,158 | $202.51 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-03 | 112 | $56.77 | 7,011 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-03 | 112 | $203.05 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-03 | 817 | $200.45 | 6,082 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-03 | 851 | $201.51 | 5,231 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-03 | 1,082 | $202.54 | 4,149 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-03 | 3,124 | $200.45 | 19,936 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2023-04-03 | 3,317 | $201.51 | 16,619 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2023-04-03 | 4,284 | $202.54 | 12,335 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-03 | 995 | $0.00 | 995 | $38.82 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-03 | 9,260 | $0.00 | 9,260 | $66.60 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-04-03 | 7,270 | $0.00 | 7,270 | $56.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-05-19 | No | 4 | M | Direct | |
| 0 | 2027-05-18 | No | 4 | M | Direct | |
| 1,990 | 2028-05-18 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.10 to $200.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.27 to $201.26. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $201.28 to $202.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $202.32 to $202.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $201.92 to $202.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.10 to $201.07. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $201.10 to $202.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $202.11 to $203.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/19/17.
- Options were fully vested on 5/18/18.
- Options were fully vested on 5/18/19.
Billionaire Hedge Funds
